New stroke drug HRS-7450 aims to reduce disability when given up to 24 hours after symptoms

NCT ID NCT07233070

First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 16 times

Summary

This study tests an investigational drug called HRS-7450 in 208 adults who have had an acute ischemic stroke (a clot blocking blood flow to the brain). Participants must receive the drug or a placebo within 4.5 to 24 hours of their first symptoms. The main goal is to see if the drug helps people recover with little or no disability 90 days later, compared to placebo. The study also checks how well the drug restores blood flow and reduces brain damage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Linyi People's Hospital

    RECRUITING

    Linyi, Shandong, 276002, China

    Contact

  • The First Affiliated Hospital of Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510062, China

    Contact

Conditions

Explore the condition pages connected to this study.